Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2013
09/18/2013CN103313988A Imidazotriazinone compounds
09/18/2013CN103313987A Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
09/18/2013CN103313979A Novel compound for organic electronic material and organic electroluminescent device using the same
09/18/2013CN103313725A Adsorption of immunopotentiators to insoluble metal salts
09/18/2013CN103304572A 3-cyanoquinoline compound as well as pharmaceutical composition and application thereof
09/18/2013CN103304569A Erlotinib-phthalocyanine conjugate and preparation method thereof
09/18/2013CN103304568A Tripolyindole compound, and preparation method and use thereof
09/18/2013CN103304567A Preparation method of ticagrelor
09/18/2013CN103304552A Substituted pyridine compound as well as application method and usage thereof
09/18/2013CN103304541A Viral polymerase inhibitors
09/18/2013CN101835780B Imidazo [1,2-alpha] pyrazine compounds for treatment of viral infections such as hepatitis
09/17/2013US8536187 2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
09/17/2013US8536174 Urotensin II receptor antagonists
09/17/2013US8536159 Organic compounds
09/17/2013US8535814 Heterocyclic compound and organic light emitting device including the same
09/17/2013CA2722418C Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
09/17/2013CA2570903C N-hydroxyamide derivatives and use thereof
09/12/2013WO2013134527A1 Synthesis of polycyclic alkaloids and their use as tgr5 agonists
09/12/2013WO2013134518A1 Sulfamide sodium channel inhibitors
09/12/2013WO2013134228A1 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
09/12/2013WO2013134226A1 Benzodioxanes for inhibiting leukotriene production
09/12/2013WO2013134142A1 Inhibitors of human immunodeficiency virus replication
09/12/2013WO2013134113A1 Fused pyrimidines as inhibitors of immunodeficiency virus replication
09/12/2013WO2013134079A1 Oxazolidinone compounds and derivatives thereof
09/12/2013WO2013133556A1 Novel triazolo pyridazine derivative and use therefor
09/12/2013WO2013133359A1 Light-emitting material, and organic light-emitting element
09/12/2013WO2013133325A1 Tricyclic compound
09/12/2013WO2013133223A1 Light emitting element
09/12/2013WO2013133219A1 Light emitting element
09/12/2013WO2013132253A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
09/12/2013WO2013131984A1 Adjuvanted formulations of rabies virus immunogens
09/12/2013WO2013131923A1 Substituted azabicycles and use thereof
09/12/2013WO2013131901A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production
09/12/2013WO2013131609A1 Triazolopyrazine derivatives
09/12/2013WO2007024945A8 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
09/12/2013US20130237544 Cdk inhibitors
09/12/2013US20130237538 Kinase inhibitors
09/12/2013US20130237537 Method of treating conditiions with kinase inhibitors
09/12/2013US20130237534 Cdk inhibitors
09/12/2013US20130237533 CDK Inhibitors
09/12/2013US20130237530 Benzodiazepine derivatives, compositions and methods for treating cognitive impairment
09/12/2013US20130237524 Synthesis of polycyclic alkaloids
09/12/2013US20130237521 Imidazopyrizine syk inhibitors
09/12/2013US20130237520 Imidazopyrazine syk inhibitors
09/12/2013US20130237499 Inhibitors of Human Immunodeficiency Virus Replication
09/12/2013US20130234075 Triphenylamine derivatives and organic photovoltaic cells including the derivatives
09/11/2013EP2635585A1 High-efficiency catalysts, preparation and use thereof
09/11/2013EP2635584A1 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
09/11/2013EP2635583A1 Coelenterazine derivatives and methods of using same
09/11/2013EP2635582A1 Novel coelenterazine substrates and methods of use
09/11/2013EP2635581A1 7-([1,2,3]triazol-4-yl)-pyrrolo[2,3-b]pyrazine derivatives
09/11/2013EP2635578A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
09/11/2013EP2635562A1 Pyrrolidine derivatives used as cathepsin inhibitors
09/11/2013EP2635275A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
09/11/2013CN203187610U Methenamine production device
09/11/2013CN1665807B Novel physiolgically active substances
09/11/2013CN103298818A Spiro-oxindole MDM2 antagonists
09/11/2013CN103298817A Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
09/11/2013CN103298816A Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
09/11/2013CN103298815A Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
09/11/2013CN103298814A 2-anilinopurin-8-ones as inhibitors of TTK/MPS1 for the treatment of proliferative disorders
09/11/2013CN103298800A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/11/2013CN103298468A Ring-fused heterocyclic derivative
09/11/2013CN103288840A Phthalocyanine-erlotinib yoke compound and preparation and application thereof
09/11/2013CN103288839A Chromatographic separation method and quantitative detection method of CL-20 (hexaazaisowurtzitane) and three intermediates CL-20
09/11/2013CN103288838A Preparation method of di-nuclear sub-phthalocyanine substance and application thereof
09/11/2013CN103288837A Preparation method of ticagrelor
09/11/2013CN103288836A Preparation method of ticagrelor
09/11/2013CN103288835A Inhibitors of E1 activating enzyme
09/11/2013CN103288834A Short-acting benzodiazepine salts and their polymorphic forms
09/11/2013CN103288833A Imidazo triazines and imidazo pyrimidines as kinase inhibitors
09/11/2013CN103288832A Pyrrolopyridazine compounds with antiviral properties
09/11/2013CN103288831A Method for synthesizing chiral dihydro-6H-benzpyrole-[2,1-c][1,4]-benzodiazepine-6-ketone
09/11/2013CN103288830A Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepine
09/11/2013CN103288829A Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one
09/11/2013CN103288828A Method for synthesizing chiral dihydro-6H-indolo[2,1-c][1,4]-benzodiazepine
09/11/2013CN102257029B Pi-electron conjugated compound, manufacturing method therefor, and pi-electron conjugated polymer obtained using same
09/11/2013CN102020647B Preparation method of 1-(2,2-difluoroethoxy)-6-trifluoromethyl-N-([1,2,4]triazolezol[1,5-C] pyrimidine-2-)benzsulfamide
09/11/2013CN101959882B 咪唑羰基化合物 Imidazole-carbonyl compound
09/11/2013CN101815713B Polycyclic compound
09/11/2013CN101679439B P70 s6激酶抑制剂 P70 s6 kinase inhibitors
09/11/2013CN101490053B Bicyclic heteroaryl compounds
09/11/2013CN101367793B Amino-quinazoline derivative with antineoplastic activity and salts thereof
09/10/2013US8530653 Enzyme inhibiting compounds
09/10/2013US8530651 Process for the preparation of anagrelide and analogues
09/10/2013US8530650 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer
09/10/2013US8530614 Porphyrin coordination polymer nanospheres and nanorods
09/10/2013US8530485 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
09/10/2013US8530482 Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates
09/10/2013US8530459 Swallowtail motifs for imparting water solubility to porphyrinic compounds
09/10/2013US8530458 High-purity large-scale preparation of stannsoporfin
09/10/2013US8530063 Compound for organic photoelectric device and organic photoelectric device including the same
09/10/2013US8529796 Charge transport compositions and electronic devices made with such compositions
09/10/2013US8529685 Azaphthalocyanines and their use in ink-jet printing
09/10/2013CA2700690C Process for producing reformatsky reagent in stable form
09/10/2013CA2650572C Novel aminopyridine derivatives having aurora a selective inhibitory action
09/10/2013CA2608490C Preparation of famciclovir and other purine derivatives
09/10/2013CA2577588C Hiv inhibiting bicyclic pyrimidine derivatives
09/06/2013WO2013130890A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors
09/06/2013WO2013130855A1 Indazole derivatives
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 573